81 related articles for article (PubMed ID: 22569001)
1. Expression of Forkhead box P3 in tumour cells causes immunoregulatory function of signet ring cell carcinoma of the stomach.
Yoshii M; Tanaka H; Ohira M; Muguruma K; Iwauchi T; Lee T; Sakurai K; Kubo N; Yashiro M; Sawada T; Hirakawa K
Br J Cancer; 2012 May; 106(10):1668-74. PubMed ID: 22569001
[TBL] [Abstract][Full Text] [Related]
2. Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer.
Ishigami S; Arigami T; Uenosono Y; Matsumoto M; Okumura H; Uchikado Y; Kita Y; Nishizono Y; Maemura K; Kijima Y; Nakajo A; Owaki T; Ueno S; Hokita S; Natsugoe S
Cancer Immunol Immunother; 2012 Oct; 61(10):1663-9. PubMed ID: 22374482
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the MT-2 Treg-like cell line in the presence and absence of forkhead box P3 (FOXP3).
McCullough MJ; Tune MK; Cabrera JC; Torres-Castillo J; He M; Feng Y; Doerschuk CM; Dang H; Beltran AS; Hagan RS; Mock JR
Immunol Cell Biol; 2024 Mar; 102(3):211-224. PubMed ID: 38288547
[TBL] [Abstract][Full Text] [Related]
4. FOXP3+ regulatory T cells and the immune escape in solid tumours.
Qiu Y; Ke S; Chen J; Qin Z; Zhang W; Yuan Y; Meng D; Zhao G; Wu K; Li B; Li D
Front Immunol; 2022; 13():982986. PubMed ID: 36569832
[TBL] [Abstract][Full Text] [Related]
5. Signet ring cell carcinoma of bladder: a dilemma between primary and metastatic.
Nisa Z
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848423
[TBL] [Abstract][Full Text] [Related]
6. What is the relevance of FoxP3 in the tumor microenvironment and cancer outcomes?
Meyiah A; Elkord E
Expert Rev Clin Immunol; 2024 Mar; ():1-7. PubMed ID: 38512803
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation exerted by galectins: a land of opportunity in rare cancers.
Díaz-Alvarez L; López-Cortés GI; Pérez-Figueroa E
Front Immunol; 2023; 14():1301025. PubMed ID: 38022609
[TBL] [Abstract][Full Text] [Related]
8. Role of CD4
Han J; Zhao L; Wu J; Diao Y; Guo Q; Yang J; Luo Y
Appl Bionics Biomech; 2022; 2022():1094607. PubMed ID: 35535325
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of coexisting histological diffuse type in stage II/III gastric cancer.
Tanaka H; Yoshii M; Imai T; Tamura T; Toyokawa T; Muguruma K; Hirakawa K; Ohira M
Mol Clin Oncol; 2021 Nov; 15(5):234. PubMed ID: 34650801
[TBL] [Abstract][Full Text] [Related]
10.
Yaegashi LB; Baldavira CM; Prieto TG; Machado-Rugolo J; Velosa APP; da Silveira LKR; Assato A; Ab'Saber AM; Falzoni R; Takagaki T; Silva PL; Teodoro WR; Capelozzi VL
Front Immunol; 2021; 12():714230. PubMed ID: 34484217
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of the Immune Regulator CXCR4 as a Novel Promising Target for Gastric Cancer.
Xue S; Ma M; Bei S; Li F; Wu C; Li H; Hu Y; Zhang X; Qian Y; Qin Z; Jiang J; Feng L
Front Immunol; 2021; 12():702615. PubMed ID: 34322132
[TBL] [Abstract][Full Text] [Related]
12. Interaction between regulatory T cells and mast cells via IL-9 and TGF-β production.
Zhao YB; Yang SH; Shen J; Deng K; Li Q; Wang Y; Cui W; Ye H
Oncol Lett; 2020 Dec; 20(6):360. PubMed ID: 33133260
[TBL] [Abstract][Full Text] [Related]
13. The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models.
Yashiro M; Matsuoka T; Ohira M
Hum Cell; 2018 Oct; 31(4):271-281. PubMed ID: 29876827
[TBL] [Abstract][Full Text] [Related]
14. Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression.
Bacigalupo ML; Carabias P; Troncoso MF
World J Gastroenterol; 2017 Aug; 23(29):5266-5281. PubMed ID: 28839427
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis.
Pereira LMS; Gomes STM; Ishak R; Vallinoto ACR
Front Immunol; 2017; 8():605. PubMed ID: 28603524
[TBL] [Abstract][Full Text] [Related]
16. Cancer-FOXP3 directly activated CCL5 to recruit FOXP3
Wang X; Lang M; Zhao T; Feng X; Zheng C; Huang C; Hao J; Dong J; Luo L; Li X; Lan C; Yu W; Yu M; Yang S; Ren H
Oncogene; 2017 May; 36(21):3048-3058. PubMed ID: 27991933
[TBL] [Abstract][Full Text] [Related]
17. Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway.
Suh JH; Won KY; Kim GY; Bae GE; Lim SJ; Sung JY; Park YK; Kim YW; Lee J
Int J Clin Exp Pathol; 2015; 8(11):14608-18. PubMed ID: 26823784
[TBL] [Abstract][Full Text] [Related]
18. CD4
Kindlund B; Sjöling Å; Yakkala C; Adamsson J; Janzon A; Hansson LE; Hermansson M; Janson P; Winqvist O; Lundin SB
Gastric Cancer; 2017 Jan; 20(1):116-125. PubMed ID: 26782287
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer.
Santhanam S; Alvarado DM; Ciorba MA
Transl Res; 2016 Jan; 167(1):67-79. PubMed ID: 26297050
[TBL] [Abstract][Full Text] [Related]
20. The functional and prognostic implications of regulatory T cells in colorectal carcinoma.
Zhang X; Kelaria S; Kerstetter J; Wang J
J Gastrointest Oncol; 2015 Jun; 6(3):307-13. PubMed ID: 26029458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
